Manufacturers may submit price changes for drugs listed on the New Brunswick Drug Plans Formulary as outlined below. Manufacturers should consider the following when submitting price changes:
- The New Brunswick Drug Plans cannot accept a submitted unit price that is higher than the listed unit price in any other jurisdiction in Canada for products listed on the Maximum Allowable Price List.
- The New Brunswick Drug Plans cannot accept a price increase that is higher than the Consumer Price Index (CPI) Based Adjustment factor for patented drug increases.
- Only products listed on the New Brunswick Drug Plans Formulary will be reviewed.